REGEMAT 3D launched a hybrid scaffold 3D bioprinting process on the REGEMAT 3D REG4Life platform designed for cartilage tissue engineering.
Public source
Publisher name
Public post
September is here, and we're back in the lab at 100%! ๐ After a well-deserved summer break, weโre hitting the ground running with more energy than ever and exciting newโฆ
Company
REGEMAT 3D
Customized Bioprinting systems and Bioreactors. Creating Life Changing Futures.
- Industry
- Biotechnology Research
- Location
- Granada, ES
- Company size
- 11โ50 employees
About REGEMAT 3D
REGEMAT3D develops customized Bioprinting Systems and Bioreactors - BMAP. We create Living Tissue Technologies. The potential of bioprinting in regenerative medicine and tissue engineering is huge. There are still many problems to be solved and many hypothesis to be tested in order to find solutions to tissue regeneration. Our mission is to develop innovative solutions in the area of bioprinting and regenerative medicine towards the clinical application of this amazing technology, to improve peopleยดs quality of life.
See moreLatest activity
Latest activity from REGEMAT 3D
3 signals
Presence & Recognition
REGEMAT 3D is hosting the II Bioengineering Meeting of Valencia on September 11th at the Universidad CEU Cardenal Herrera.
Presence & Recognition
REGEMAT 3D announced that the preliminary agenda for the II Encuentro de Bioingenierรญa de Valencia is set for September 11, 2026, with presentations by Josรฉ Manuel Baena, Ph.D., Ana Pรฉrez Ruiz, Susana Herrero Oliva, Adriรกn A. Universidad CEU Cardenal Herrera, and Jose Luis Aparicio Collado, PhD.
Discover more
Similar signals
Similar public activity from other companies.
Products & Services
Ossiform
Ossiform provides researchers with standardized platform for bone research using P3D Scaffolds, including 5 mm diameter grid scaffolds.
Products & Services
Boston Micro Fabrication - BMF
Boston Micro Fabrication - BMF printed a biologically-inspired vascular network with 120ฮผm channels built for real-time flow visualization in organ-on-chip and tissue engineering work.
Products & Services
NovusTex, Corp.
NovusTex, Corp. is advancing NasalCartโข, its human-relevant 3D bioprinted nasal tissue platform for intranasal drug development toward manufacturing, pilot validation, and commercialization.
Research & Knowledge
Humabiologicsยฎ, Inc
Humabiologicsยฎ, Inc published research from Rice University studying human and porcine gelatin-based composite hydrogels and their applicability as bioinks for osteochondral tissue engineering through 3D bioprinting.
Products & Services
Munich Medical Devices GmbH